Neumora Therapeutics, Inc. (NMRA) Insider Trading -- Recent Executive & Director Transactions

23 insiders reported 30 Form 4 transactions for Neumora Therapeutics, Inc. (NMRA) over the past 18 months (most recent 2026-02-19). Recent activity: Pinto Joshua (President) Sell 5,967 shares, Milligan Michael Lee (See Remarks) Sell 1,436 shares, Aurora Daljit Singh (See Remarks) Sell 6,165 shares, BERNS PAUL L (See Remarks) Sell 9,819 shares, Aurora Daljit Singh (See Remarks) Sell 114,703 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-02-19Pinto JoshuaPresidentSell5,967$21,123
2026-02-19Milligan Michael LeeSee RemarksSell1,436$5,127
2026-02-19Aurora Daljit SinghSee RemarksSell6,165$21,947
2026-02-19BERNS PAUL LSee RemarksSell9,819$34,465
2025-11-13Aurora Daljit SinghSee RemarksSell114,703$307,404
2025-10-29ARCH Venture Partners XII, L.P.InsiderBuy1.9M$5.0M
2025-10-29CRANDELL KEITHInsiderBuy1.9M$5.0M
2025-10-29NELSEN ROBERTInsiderBuy1.9M$5.0M
2025-10-29BYBEE CLINTONInsiderBuy1.9M$5.0M
2025-10-29GILLIS STEVENInsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Fund XII, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners XII, LLCInsiderBuy1.9M$5.0M
2025-10-29Burow KristinaDirectorBuy1.9M$5.0M
2025-10-29ARCH Venture Fund VII, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners VII, LLCInsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners VII, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners VIII, LLCInsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Fund VIII Overage, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Fund X, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Fund X Overage, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners X Overage, L.P.InsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners X, LLCInsiderBuy1.9M$5.0M
2025-10-29ARCH Venture Partners X, L.P.InsiderBuy1.9M$5.0M
2025-05-23Pinto JoshuaPresidentSell13,202$0
2025-05-23Pinto JoshuaPresidentBuy13,202$0

Source: SEC Form 4 filings · as of 2026-02-19